Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis

European Respiratory Journal

Volumn 21, Issue 5, 2003, Pages 743-748

  Koulouris, N G ^a   Retsou, S ^a   Kosmas, E ^a   Dimakou, K ^a   Malagari, K ^a   Mantzikopoulos, G ^a   Koutsoukou, A ^a   Milic Emili, J ^b   Jordanoglu, J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bronchiectasis; Exercise; High resolution computed tomography; Negative expiratory pressure; Pulmonary function; Respiratory mechanics

Indexed keywords

ADULT; AGED; ARTICLE; BREATHING; BRONCHIECTASIS; CAUCASIAN; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ERGOMETER; EXERCISE; EXPIRATORY FLOW; EXPIRATORY FLOW RATE; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SITTING; SUPINE POSITION; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; POSTURE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038394705     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00301103     Document Type: Article

References (26)

1. Kolbe J, Wells AU. Bronchiectasis: A neglected cause of respiratory morbidity and mortality. Respirology 1996; 1: 221-225.
2. Pande JN, Jain BP, Gupta RG, Guleria GS. Pulmonary ventilation and gas exchange in bronchiectasis. Thorax 1971; 26: 727-733.
3. Ip M, Lauder LJ, Wong WY, Lam WK, So SY. Multivariate analysis of factors affecting pulmonary function in bronchiectasis. Respiration 1993; 60: 45-50.
4. Cherniack NS, Vosti KL, Saxton GA, Lepper MH, Dowling HF. Pulmonary function tests in fifty patients with bronchiectasis. J Lab Clin Med 1959; 53: 693-706.
5. Cherniack NS, Carton RW. Factors associated with respiratory insufficiency in bronchiectasis. Amer J Med 1966; 41: 562-571.
6. Smith IE, Jurriaans E, Diederich S, Ali N, Shneerson JM, Flower CDR. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the thorax. Thorax 1996; 51: 914-918.
7. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis 1982; 126: 166-170.
8. Valta P, Corbeil C, Lavoie A, et al. Detection of expiratory flow limitation during mechanical ventilation. Am J Respir Crit Care Med 1994; 150: 1311-1317.
9. Tantucci C, Ellaffi M, Duguet A, et al. Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 1999; 14: 295-301.
10. Sulc J, Volta CA, Ploysongsang Y, Eltayara L, Olivenstein R, Milic-Emili J. Flow limitation and dyspnoea in healthy supine subjects during methacholine challenge. Eur Respir J 1999; 14: 1326-1331.
11. Diaz O, Villafranca C, Ghezzo H, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-275.
12. Diaz O, Villafranca C, Ghezzo H, et al. Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2001; 17: 1120-1127.
13. Goetghebeur D, Sarni D, Grossi Y, et al. Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis. Eur Respir J 2002; 19: 492-498.
14. Regnis JA, Donnell PM, Robinson M, Alison JA, Bye PT. Ventilatory mechanics at rest and during exercise in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 154: 1418-1425.
15. Mahler DA, Harver A. Measurement of symptoms: the benchmark of treatment. Minimizing the effects of dyspnea in COPD patients. J Respir Dis 1987; 8: 23-34.
16. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1726-1734.
17. Quanjer PhH (ed). Standardized lung function testing. Report Working Party "Standardization of Lung Function Tests", European Community for Coal and Steel. Eur Respir J 1993; 6: Suppl. 16, 1-100.
18. Koulouris NG, Valta P, Lavoie A, et al. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995; 8: 306-313.
19. Koulouris NG, Dimopoulou I, Valta P, Finkelstein R, Cosio MG, Milic-Emili J. Detection of expiratory flow limitation during exercise in COPD patients. J Appl Physiol 1997; 82: 723-731.
20. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
21. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: Scoring system with thin-section CT. Radiology 1991; 179: 783-788.
22. Jones NL. Interpretation of stage I exercise test results. In: Jones NL, ed. Clinical Exercise Testing. WB Saunders, Philadelphia, USA, 1997; pp. 124-149.
23. Baydur A, Milic-Emili J. Expiratory flow limitation during spontaneous breathing. Comparison of patients with restrictive and obstructive respiratory disorders. Chest 1997; 112: 1017-1023.
24. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000; 55: 198-204.
25. Wong-You-Cheong JJ, Leahy BC, Taylor PM, Church SE. Airways obstruction and bronchiectasis: Correlation with duration of symptoms and extent of bronchiectasis on computed tomography. Clin Radiol 1992; 45: 256-259.
26. Evans SA, Turner SM, Bosch BJ, Hardy CC, Woodhead MA. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996; 9: 1601-1604.